Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. (atsiveria naujas langas)

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Šaltinis‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Kodas‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 (atsiveria naujas langas)

High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institution. (atsiveria naujas langas)

Azzarà A, Carulli G, Galimberti S, Baratè C, Fazzi R, Cervetti G, Petrini M.

Šaltinis‎: Am J Hematol 2011;86(9):762-7.

Kodas‎: PubMed 21850658

DOI‎: 10.1002/ajh.22111

https://www.ncbi.nlm.nih.gov/pubmed/21850658 (atsiveria naujas langas)

Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. (atsiveria naujas langas)

Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA.

Šaltinis‎: Acta Haematol 2007;117(3):162-7.

Kodas‎: PubMed 17148935

DOI‎: 10.1159/000097464

https://www.ncbi.nlm.nih.gov/pubmed/17148935 (atsiveria naujas langas)

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial. (atsiveria naujas langas)

Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F.

Šaltinis‎: Am J Hematol 2013;88(12):990-6.

Kodas‎: PubMed 23873823

DOI‎: 10.1002/ajh.23552

https://www.ncbi.nlm.nih.gov/pubmed/23873823 (atsiveria naujas langas)

Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study. (atsiveria naujas langas)

Blohmer JU, Paepke S, Sehouli J, Boehmer D, Kolben M, Würschmidt F, Petry KU, Kimmig R, Elling D, Thomssen C, von Minckwitz G, Möbus V, Hinke A, Kümmel S, Budach V, Lichtenegger W, Schmid P.

Šaltinis‎: J Clin Oncol 2011;29(28):3791-7.

Kodas‎: PubMed 21860000

DOI‎: 10.1200/JCO.2010.30.4899

https://www.ncbi.nlm.nih.gov/pubmed/21860000 (atsiveria naujas langas)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (atsiveria naujas langas)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Šaltinis‎: Cancer 2012;118(3):848-55.

Kodas‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (atsiveria naujas langas)

Management of anemia in cancer patients. (atsiveria naujas langas)

Calabrich A, Katz A.

Šaltinis‎: Future Oncol 2011;7(4):507-17.

Kodas‎: PubMed 21463140

DOI‎: 10.2217/fon.11.24

https://www.ncbi.nlm.nih.gov/pubmed/21463140 (atsiveria naujas langas)

Leczenie ostrej białaczki u Świadków Jehowy—opis przypadku i przegląd piśmiennictwa. [Treatment of acute leukemia in Jehovah's Witnesses—a case report and review of the literature.] [Polish, English abstract] (atsiveria naujas langas)

Chojnowski K, Trelinski J.

Šaltinis‎: Acta Haematol Pol 2007;38(4):479-84.

Kodas‎: EMBASE 2008089811

https://web.archive.org/web/20210506152723/https:/pthit.pl/Acta_Haematologica_Polonica,Ostra_bialaczka_Chemioterapia_Swiadkowie_Jehowy_Przetoczenie_krwi,395.html (atsiveria naujas langas)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (atsiveria naujas langas)

Deger M, Eisterer W, Kutikova L, Salek S.

Šaltinis‎: Support Care Cancer 2013;21(2):485-93.

Kodas‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

https://www.ncbi.nlm.nih.gov/pubmed/22825456 (atsiveria naujas langas)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (atsiveria naujas langas)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Šaltinis‎: BJU Int 2011;108(10):1582-7.

Kodas‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (atsiveria naujas langas)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (atsiveria naujas langas)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Šaltinis‎: J Clin Oncol 2010;28(13):2239-45.

Kodas‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (atsiveria naujas langas)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (atsiveria naujas langas)

Ford PA, Grant SJ, Mick R, Keck G.

Šaltinis‎: J Clin Oncol 2015;33(15):1674-9.

Kodas‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (atsiveria naujas langas)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation. (atsiveria naujas langas)

Fujisaka Y, Sugiyama T, Saito H, Nagase S, Kudoh S, Endo M, Sakai H, Ohashi Y, Saijo N.

Šaltinis‎: Br J Cancer 2011;105(9):1267-72.

Kodas‎: PubMed 21959870

DOI‎: 10.1038/bjc.2011.395

https://www.ncbi.nlm.nih.gov/pubmed/21959870 (atsiveria naujas langas)

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome. (atsiveria naujas langas)

Garelius HK, Johnston WT, Smith AG, Park S, de Swart L, Fenaux P, Symeonidis A, Sanz G, Čermák J, Stauder R, Malcovati L, Mittelman M, van de Loosdrecht AA, van Marrewijk CJ, Bowen D, Crouch S, de Witte TJ, Hellström-Lindberg E.

Šaltinis‎: J Intern Med 2017;281(3):284-99.

Kodas‎: PubMed 27926979

DOI‎: 10.1111/joim.12579

https://www.ncbi.nlm.nih.gov/pubmed/27926979 (atsiveria naujas langas)

How I treat cancer-associated anemia. (atsiveria naujas langas)

Gilreath JA, Rodgers GM

Šaltinis‎: Blood 2020;136(7):801-13.

Kodas‎: PubMed 32556170

DOI‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 (atsiveria naujas langas)

Update on safety of ESAs in cancer-induced anemia. (atsiveria naujas langas)

Glaspy J.

Šaltinis‎: J Natl Compr Canc Netw 2012;10(5):659-66.

Kodas‎: PubMed 22570294

https://www.ncbi.nlm.nih.gov/pubmed/22570294 (atsiveria naujas langas)

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. (atsiveria naujas langas)

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

Šaltinis‎: Eur J Haematol. 2023 110(4):354-61.

Kodas‎: PubMed 36480004

DOI‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ (atsiveria naujas langas)

A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes. (atsiveria naujas langas)

Jang JH, Harada H, Shibayama H, Shimazaki R, Kim HJ, Sawada K, Mitani K.

Šaltinis‎: Int J Hematol 2015;102(4):401-12.

Kodas‎: PubMed 26323997

DOI‎: 10.1007/s12185-015-1862-5

https://www.ncbi.nlm.nih.gov/pubmed/26323997 (atsiveria naujas langas)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (atsiveria naujas langas)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Šaltinis‎: Cancer 2013;119(1):107-14.

Kodas‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (atsiveria naujas langas)

Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. (atsiveria naujas langas)

Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, du Bois A, Thomssen C, Kurbacher C, Kuhn W, Nitz U, Runnebaum IB, Hinke A, Kreienberg R, Untch M; on behalf of the AGO Breast Study Group.

Šaltinis‎: J Natl Cancer Inst 2013;105(14):1018-26.

Kodas‎: PubMed 23860204

DOI‎: 10.1093/jnci/djt145

https://www.ncbi.nlm.nih.gov/pubmed/23860204 (atsiveria naujas langas)

Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials. (atsiveria naujas langas)

Ohashi Y, Uemura Y, Fujisaka Y, Sugiyama T, Ohmatsu H, Katsumata N, Okamoto R, Saijo N, Hotta T.

Šaltinis‎: Cancer Sci 2013;104(4):481-5.

Kodas‎: PubMed 23331490

DOI‎: 10.1111/cas.12105

https://www.ncbi.nlm.nih.gov/pubmed/23331490 (atsiveria naujas langas)

Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review. (atsiveria naujas langas)

Park S, Greenberg P, Yucel A, Farmer C, O'Neill F, De Oliveira Brandao C, Fenaux P

Šaltinis‎: Br J Haematol 2019;184(2):134-60.

Kodas‎: PubMed 30549002

DOI‎: 10.1111/bjh.15707

https://www.ncbi.nlm.nih.gov/pubmed/30549002 (atsiveria naujas langas)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (atsiveria naujas langas)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Šaltinis‎: Support Care Cancer 2012;20(1):159-65.

Kodas‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (atsiveria naujas langas)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (atsiveria naujas langas)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Šaltinis‎: Leuk Lymphoma. 2019;60(9):2324-7.

Kodas‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (atsiveria naujas langas)

Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. (atsiveria naujas langas)

Pronzato P, Cortesi E, van der Rijt CC, Bols A, Moreno-Nogueira JA, de Oliveira CF, Barrett-Lee P, Ostler PJ, Rosso R; for the EPO-INT-47 Study Group.

Šaltinis‎: Oncologist 2010;15(9):935-43.

Kodas‎: PubMed 20798194

DOI‎: 10.1634/theoncologist.2009-0279

https://www.ncbi.nlm.nih.gov/pubmed/20798194 (atsiveria naujas langas)

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. (atsiveria naujas langas)

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.

Šaltinis‎: Lung Cancer 2012;76(3):478-85.

Kodas‎: PubMed 22277104

DOI‎: 10.1016/j.lungcan.2011.12.015

https://www.ncbi.nlm.nih.gov/pubmed/22277104 (atsiveria naujas langas)

Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia. (atsiveria naujas langas)

Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G.

Šaltinis‎: Eur J Haematol 2016;97(1):33-8.

Kodas‎: PubMed 26341961

DOI‎: 10.1111/ejh.12679

https://www.ncbi.nlm.nih.gov/pubmed/26341961 (atsiveria naujas langas)

Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. (atsiveria naujas langas)

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee

Šaltinis‎: Ann Oncol 2018;29(Supplement_4):iv96-110.

Kodas‎: PubMed 29471514

DOI‎: 10.1093/annonc/mdx758

https://www.ncbi.nlm.nih.gov/pubmed/29471514 (atsiveria naujas langas)

Intravenous iron in oncology. (atsiveria naujas langas)

Auerbach M, Ballard H.

Šaltinis‎: J Natl Compr Canc Netw 2008;6(6):585-92.

Kodas‎: PubMed 18597712

https://www.ncbi.nlm.nih.gov/pubmed/18597712 (atsiveria naujas langas)

Intravenous iron supplementation for the treatment of chemotherapy-induced anemia: a systematic review and meta-analysis of randomized controlled trials. (atsiveria naujas langas)

Buchrits S, Itzhaki O, Avni T, Raanani P, Gafter-Gvili A

Šaltinis‎: J Clin Med. 2022;11(14):4156.

Kodas‎: PubMed 35887920

DOI‎: 10.3390/jcm11144156

https://pubmed.ncbi.nlm.nih.gov/35887920/ (atsiveria naujas langas)

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. (atsiveria naujas langas)

Calleja JL, Delgado S, Del Val A, Hervás A, Larraona JL, Terán Á, Cucala M, Mearin F; Colon Cancer Study Group.

Šaltinis‎: Int J Colorectal Dis 2016;31(3):543-51.

Kodas‎: PubMed 26694926

DOI‎: 10.1007/s00384-015-2461-x

https://www.ncbi.nlm.nih.gov/pubmed/26694926 (atsiveria naujas langas)

How I treat cancer-associated anemia. (atsiveria naujas langas)

Gilreath JA, Rodgers GM

Šaltinis‎: Blood 2020;136(7):801-13.

Kodas‎: PubMed 32556170

DOI‎: 10.1182/blood.2019004017

https://www.ncbi.nlm.nih.gov/pubmed/32556170 (atsiveria naujas langas)

Total dose iron dextran infusion in cancer patients: is it SaFe2+? (atsiveria naujas langas)

Gilreath JA, Stenehjem DD, Rodgers GM.

Šaltinis‎: J Natl Compr Canc Netw 2012;10(5):669-76.

Kodas‎: PubMed 22570295

https://www.ncbi.nlm.nih.gov/pubmed/22570295 (atsiveria naujas langas)

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron. (atsiveria naujas langas)

Henry DH, Dahl NV, Auerbach MA.

Šaltinis‎: Am J Hematol 2012;87(3):308-10.

Kodas‎: PubMed 22262486

DOI‎: 10.1002/ajh.22262

https://www.ncbi.nlm.nih.gov/pubmed/22262486 (atsiveria naujas langas)

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia. (atsiveria naujas langas)

Inzoli E, Crisà E, Pugliese N, Civettini I, Lanzarone G, Castelli A, Martinelli V, Montelisciani L, Antolini L, Gambacorti-Passerini C, Elli EM

Šaltinis‎: Eur J Haematol. 2023 110(4):354-61.

Kodas‎: PubMed 36480004

DOI‎: 10.1111/ejh.13910

https://pubmed.ncbi.nlm.nih.gov/36480004/ (atsiveria naujas langas)

Intravenous iron therapy to treat anemia in oncology: a mapping review of randomized controlled trials. (atsiveria naujas langas)

Lim J, Auerbach M, MacLean B, Al-Sharea A, Richards T

Šaltinis‎: Curr Oncol. 2023 24;30(9):7836-51.

Kodas‎: PubMed 37754484

DOI‎: 10.3390/curroncol30090569

https://pubmed.ncbi.nlm.nih.gov/37754484/ (atsiveria naujas langas)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (atsiveria naujas langas)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Šaltinis‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Kodas‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (atsiveria naujas langas)

Perioperative anemia management in colorectal cancer patients: a pragmatic approach. (atsiveria naujas langas)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Auerbach M.

Šaltinis‎: World J Gastroenterol 2014;20(8):1972-85.

Kodas‎: PubMed 24587673

DOI‎: 10.3748/wjg.v20.i8.1972

https://www.ncbi.nlm.nih.gov/pubmed/24587673 (atsiveria naujas langas)

Practical clinical consensus guidelines for the management of cancer associated anemia in low- and middle-income countries. (atsiveria naujas langas)

Parikh PM, Aggarwal S, Biswas G, Gulia S, Agarwala V, Basade M, Mohapatra PN, Vamshi KM, Warrier A, Prasad K, Roy P, Chandrakant MV, Malhotra H, Hingmire S, Paul D, Maniar V, Gupta A, Panda SS, Samar A, Rohatgi N, Dattatreya S, Krishnamurthy M, Thirumalairaj R

Šaltinis‎: South Asian J Cancer. 2023 15;12(2):93-9.

Kodas‎: PubMed 37969669

DOI‎: 10.1055/s-0043-1771445

https://pubmed.ncbi.nlm.nih.gov/37969669/ (atsiveria naujas langas)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (atsiveria naujas langas)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Šaltinis‎: J Clin Oncol 2008;26(10):1619-25.

Kodas‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (atsiveria naujas langas)

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials. (atsiveria naujas langas)

Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S.

Šaltinis‎: J Cancer Res Clin Oncol 2012;138(2):179-87.

Kodas‎: PubMed 21972052

DOI‎: 10.1007/s00432-011-1072-3

https://www.ncbi.nlm.nih.gov/pubmed/21972052 (atsiveria naujas langas)

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. (atsiveria naujas langas)

Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.

Šaltinis‎: Ann Oncol 2013;24(2):475-82.

Kodas‎: PubMed 23071262

DOI‎: 10.1093/annonc/mds338

https://www.ncbi.nlm.nih.gov/pubmed/23071262 (atsiveria naujas langas)

Expert consensus guidelines: intravenous iron uses, formulations, administration, and management of reactions. (atsiveria naujas langas)

Van Doren L, Steinheiser M, Boykin K, Taylor KJ, Menendez M, Auerbach M

Šaltinis‎: Am J Hematol 2024;99(7):1338-48.

Kodas‎: PubMed 38282557

DOI‎: 10.1002/ajh.27220

https://pubmed.ncbi.nlm.nih.gov/38282557/ (atsiveria naujas langas)